LOGIN
Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk
November 2020
Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Polypill with or without Aspirin in Persons without Cardiovascular Disease
N Engl J Med. 2020 Nov 13.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Five thousand, seven hundred and thirteen patients with elevated cardiovascular risk were randomized to receive a polypill (containing lipid and blood pressuring lowering agents), aspirin, polypill and aspirin, or placebo for the prevention of cardiovascular events. The primary outcome of interest for the polypill and polypill plus aspirin groups was a composite of death from major cardiovascular ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.